Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CCR8 | P51685 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14469476 | 0.92 | FAAH (0.50) | FAAHKDM4EPOLBCCR8ALDH1A1 | |
| SCHEMBL14469462 | 0.90 | FAAH (0.50) | FAAHKDM4EPOLBALDH1A1LMNA | |
| SCHEMBL14469472 | 0.89 | FAAH (0.51) | FAAHKDM4EPOLBCCR8ALDH1A1 | |
| SCHEMBL14469456 | 0.85 | SMN1; SMN2 (0.50) | FAAHKDM4EPOLBALDH1A1HTT | |
| SCHEMBL14469463 | 0.83 | KDM4E (0.48) | KDM4EPOLBALDH1A1LMNAHTT | |
| SCHEMBL14469553 | 0.83 | KDM4E (0.61) | FAAHKDM4EPOLBALDH1A1LMNA | |
| SCHEMBL14456818 | 0.82 | FAAH (0.60) | FAAHKDM4EPOLBCCR8CYP3A4 | |
| SCHEMBL14469464 | 0.82 | MEN1 (0.45) | KDM4EPOLBALDH1A1LMNAHTT | |
| SCHEMBL14469559 | 0.82 | KDM4E (0.46) | KDM4EPOLBALDH1A1LMNAHTT | |
| SCHEMBL14469179 | 0.81 | ADRB2 (0.54) | FAAHKDM4EPOLBALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007075555-A2 | COMBINATION OF AN H3 ANTAGONIST/INVERSE AGONIST AND AN APPETITE SUPPRESSANT | SCHERING CORPORATION (US) | 2007-07-05 | — | — | WO | disclosed |